Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Colorcon
Healthtrust
Chinese Patent Office
Boehringer Ingelheim
Argus Health
Fish and Richardson
Federal Trade Commission
Chubb
Teva

Generated: October 16, 2017

DrugPatentWatch Database Preview

Mayne Pharma Intl Company Profile

« Back to Dashboard

What is the competitive landscape for MAYNE PHARMA INTL, and what generic and branded alternatives to MAYNE PHARMA INTL drugs are available?

MAYNE PHARMA INTL has one approved drug.



Summary for Applicant: Mayne Pharma Intl

US Patents:0
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Intl
DORYX
doxycycline hyclate
CAPSULE, DELAYED RELEASE;ORAL050582-002Aug 13, 2001DISCNYesNo► Subscribe► Subscribe► Subscribe
Mayne Pharma Intl
DORYX
doxycycline hyclate
CAPSULE, DELAYED RELEASE;ORAL050582-001Jul 22, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MAYNE PHARMA INTL drugs

Drugname Dosage Strength Tradename Submissiondate
doxycycline hyclate
Delayed-release Tablets50 mg
DORYX
11/5/2015
doxycycline hyclate
Delayed-release Tablets80 mg
DORYX
7/1/2015
doxycycline hyclate
Delayed-release Tablets200 mg
DORYX
5/19/2014
doxycycline hyclate (as of 6/10/14)
Delayed-release Tablets200 mg
DORYX
8/12/2013
doxycycline hyclate
Delayed-release Tablets150 mg
DORYX
12/19/2008

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Moodys
Baxter
US Army
US Department of Justice
Cantor Fitzgerald
Chinese Patent Office
Johnson and Johnson
Citi
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot